Evidence map›Paper›PMID 42290596›Full record

ArticleAmerican journal of hematology2026

Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders.

Madeline Franke, Rachel Kirchner, Bianca Barredo, Amar Zaidan, Sara Torres-Esquius, Pamela Acha, Sandra Novoa-Jáuregui, Maria Julia Montoro, Jane E Churpek, Daria V Babushok and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Madeline FrankeDepartment of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-9573-3607
Rachel KirchnerDivision of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Bianca BarredoDivision of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Amar ZaidanDivision of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Pennsylvania, Philadelphia, USA.
Sara Torres-EsquiusDepartment of Hematology, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.ORCID https://orcid.org/0000-0001-7540-7284
Pamela AchaDepartment of Hematology, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Sandra Novoa-JáureguiDepartment of Hematology, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Maria Julia MontoroDepartment of Hematology, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9532-7417
Jane E ChurpekDivision of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0001-7998-5479
Daria V BabushokDivision of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Pennsylvania, Philadelphia, USA.ORCID https://orcid.org/0000-0002-1745-0353
Terra LashoDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-0315-5230
Tariq KewanDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Olisameka OgbueDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abhishek MangaonkarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-2458-9887
Andrés JerezDepartment of Hematology, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Alejandro FerrerDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Mrinal M PatnaikDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0001-6998-662X

Funding

Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
NIGMS NIH HHS T32 GM140935
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clonal hematopoiesissomatic mosaicismtelomere biology disordersTERT

Identifiers

PMID42290596
PMCPMC13428376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.